BIOMAT Database Logo BIOMAT Database Logo

Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages. 1991

M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Departamento de Biologia, Universidade de São Paulo, Brazil.

In order to investigate if the same apparent decrease in dystrophin negative fibers with aging observed in mouse mdx female heterozygotes also occurs in carriers of the DMD and BMD gene, we have studied the muscle of 29 DMD carriers (19 adults and 10 young daughters of obligate carriers, including 3 manifesting carriers) and 5 adult asymptomatic heterozygotes for Becker dystrophy (BMD). All young DMD possible carriers and 11 of 24 adult DMB/BMD heterozygotes had increased serum enzymes activities. A population of dystrophin negative fibers, more evident with the use of the C-terminal antibody, was seen in the three manifesting and in a 9-yr-old possible DMD carrier. In the remaining females, a positive immunohistochemical pattern of dystrophin, which did not differ from normal controls, was observed. Our results suggest that: (1) the increased population of dystrophin negative fibers reported in young mdx female heterozygotes was not seen in young DMD carriers, aged 6-17 yr; and (2) abnormalities in dystrophin immunostaining are not easily observed and are more frequent in manifesting carriers, when the muscle is grossly altered.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes

Related Publications

M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Asymptomatic Becker muscular dystrophy: expression of dystrophin and dystrophin-related protein.
January 1993, Pediatric neurology,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
October 1996, Acta neuropathologica,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
December 2005, Neurology,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies.
May 2015, Bosnian journal of basic medical sciences,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
January 1989, The New England journal of medicine,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies.
February 2003, Neuromuscular disorders : NMD,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies.
July 2015, Bosnian journal of basic medical sciences,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Dystrophin and Duchenne's muscular dystrophy.
August 1989, The New England journal of medicine,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
August 2000, Neuromuscular disorders : NMD,
M Vainzof, and R C Pavanello, and I Pavanello, and A M Tsanaclis, and J A Levy, and M R Passos-Bueno, and D Rapaport, and M Zatz
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.
May 1996, JAMA,
Copied contents to your clipboard!